Open access
Jul 2026
CRABP2 Promotes Lung Adenocarcinoma Through Retinoic Acid Pathway-Mediated NF-κB Activation.
A CRABP2/RA/NF‑κB axis that drives LUAD progression is established, highlighting this pathway as a potential therapeutic target for intervention in LUAD.
Xi-Rui Zhu, Biao Fan, Qingyang Lei et al.
· Frontiers in Bioscience · 0 citations